Science & Technology

Cohance Lifesciences :About Us :Science & Technology

Cohance’s scientific and technological prowess sets us apart as a leader in the CDMO industry. Our innovation-driven approach leverages advanced technologies and deep expertise to deliver differentiated solutions:

Advanced Chemistries

Advanced Chemistries

Expertise in flow chemistry, high-pressure reactions, cryogenics, and chiral synthesis.

Next-Gen Platforms

Next-Gen-Platforms

Specialized capabilities in ADCs, oligonucleotides, and high-potency APIs.

R&D Excellence

Sustainability Focus (2)

State-of-the-art R&D centers, including Genome Valley (Hyderabad), NJ Bio (Princeton, US) and Sapala Organics (Hyderabad), equipped with cutting-edge tools like 400 MHz NMR, HPLC, and flow chemistry reactors.

R&D Highlights

Proven Track Record

  • 34+ years of CDMO expertise delivering innovation across phases and geographies.
  • 1,000+ projects successfully delivered with deep therapeutic area coverage.
  • > 90% On-Time, In-Full (OTIF) performance ensuring reliability and trust.

Scientific Depth & Talent

  • 400+ scientists, including 100+ dedicated to process R&D.
  • 15+ years of average experience in process R&D and scale-up across our scientific team.
  • > 15%+ of our scientists are PhD-qualified, bringing deep scientific expertise to every project.

Infrastructure & Capabilities

  • 3 fully equipped R&D centers, strategically located for lab-to-plant continuity.
  • 250+ unique chemistries and 300+ synthetic routes developed, from simple syntheses to complex, multi-step processes.
  • 120+ optimized routes for yield, cost-efficiency, and sustainability.
  • 150+ non-GMP and 400+ cGMP projects executed across Phases I–III.

Innovation-Driven Delivery

  • Strong expertise in complex scale-up, bridging science and execution.
  • Problem-solving mindset to address advanced chemistry challenges.
  • Full lifecycle support, from development to commercialization.